Half-year report · Q2
4323.TEDINET S100UP5I
Period2024-04-01 → 2024-09-30
Filed2024-11-12
StandardJapan GAAP
ConsolidatedYes
Data checks14 of 14 passed
Key figures · 44
| Metric | Value | Period | Scope | Source row |
|---|---|---|---|---|
| Revenue | ¥13.3bn | 2024-04-01 → 2024-09-30 | Cons. | Net sales |
| Revenue | ¥26.2bn | 2023-04-01 → 2024-03-31 | Cons. | Net sales (5-year summary) |
| Revenue | ¥12.1bn | 2023-04-01 → 2023-09-30 | Cons. | Net sales |
| Operating income | ¥1.0bn | 2024-04-01 → 2024-09-30 | Cons. | Operating income |
| Operating income | ¥1.0bn | 2023-04-01 → 2023-09-30 | Cons. | Operating income |
| Ordinary income | ¥1.1bn | 2024-04-01 → 2024-09-30 | Cons. | Ordinary income |
| Ordinary income | ¥2.9bn | 2023-04-01 → 2024-03-31 | Cons. | Ordinary income loss (5-year summary) |
| Ordinary income | ¥1.0bn | 2023-04-01 → 2023-09-30 | Cons. | Ordinary income |
| Profit before tax | ¥1.1bn | 2024-04-01 → 2024-09-30 | Cons. | Income before income taxes |
| Profit before tax | ¥1.0bn | 2023-04-01 → 2023-09-30 | Cons. | Income before income taxes |
| Net income (owners) | ¥672m | 2024-04-01 → 2024-09-30 | Cons. | Profit loss attributable to owners of parent |
| Net income (owners) | ¥2.1bn | 2023-04-01 → 2024-03-31 | Cons. | Profit loss attributable to owners of parent (5-year summary) |
| Net income (owners) | ¥651m | 2023-04-01 → 2023-09-30 | Cons. | Profit loss attributable to owners of parent |
| Net income | ¥677m | 2024-04-01 → 2024-09-30 | Cons. | Profit loss |
| Net income | ¥649m | 2023-04-01 → 2023-09-30 | Cons. | Profit loss |
| Total assets | ¥20.0bn | at 2024-09-30 | Cons. | Assets |
| Total assets | ¥20.0bn | at 2024-03-31 | Cons. | Assets |
| Total assets | ¥18.5bn | at 2023-09-30 | Cons. | Total assets (5-year summary) |
| Total liabilities | ¥7.0bn | at 2024-09-30 | Cons. | Liabilities |
| Total liabilities | ¥7.3bn | at 2024-03-31 | Cons. | Liabilities |
| Net assets / equity | ¥13.0bn | at 2024-09-30 | Cons. | Net assets |
| Net assets / equity | ¥12.7bn | at 2024-03-31 | Cons. | Net assets |
| Net assets / equity | ¥11.1bn | at 2023-09-30 | Cons. | Net assets (5-year summary) |
| Cash and deposits | ¥7.7bn | at 2024-09-30 | Cons. | Cash and deposits |
| Cash and deposits | ¥8.0bn | at 2024-03-31 | Cons. | Cash and deposits |
| Cash & equivalents | ¥7.1bn | at 2024-09-30 | Cons. | Cash and cash equivalents |
| Cash & equivalents | ¥7.5bn | at 2024-03-31 | Cons. | Cash and cash equivalents |
| Cash & equivalents | ¥7.1bn | at 2023-09-30 | Cons. | Cash and cash equivalents |
| Cash & equivalents | ¥6.8bn | at 2023-03-31d | Cons. | Cash and cash equivalents |
| Operating cash flow | ¥588m | 2024-04-01 → 2024-09-30 | Cons. | Net cash provided by used in operating activities |
| Operating cash flow | ¥1.9bn | 2023-04-01 → 2024-03-31 | Cons. | Net cash provided by used in operating activities (5-year summary) |
| Operating cash flow | ¥929m | 2023-04-01 → 2023-09-30 | Cons. | Net cash provided by used in operating activities |
| Investing cash flow | −¥433m | 2024-04-01 → 2024-09-30 | Cons. | Net cash provided by used in investment activities |
| Investing cash flow | −¥761m | 2023-04-01 → 2024-03-31 | Cons. | Net cash provided by used in investing activities (5-year summary) |
| Investing cash flow | −¥220m | 2023-04-01 → 2023-09-30 | Cons. | Net cash provided by used in investment activities |
| Financing cash flow | −¥588m | 2024-04-01 → 2024-09-30 | Cons. | Net cash provided by used in financing activities |
| Financing cash flow | −¥424m | 2023-04-01 → 2024-03-31 | Cons. | Net cash provided by used in financing activities (5-year summary) |
| Financing cash flow | −¥409m | 2023-04-01 → 2023-09-30 | Cons. | Net cash provided by used in financing activities |
| EPS (basic) | ¥27.38 | 2024-04-01 → 2024-09-30 | Cons. | Basic earnings loss per share (5-year summary) |
| EPS (basic) | ¥85.08 | 2023-04-01 → 2024-03-31 | Cons. | Basic earnings loss per share (5-year summary) |
| EPS (basic) | ¥26.55 | 2023-04-01 → 2023-09-30 | Cons. | Basic earnings loss per share (5-year summary) |
| Equity ratio | 64.7% | at 2024-09-30 | Cons. | Equity to asset ratio (5-year summary) |
| Equity ratio | 63.2% | at 2024-03-31 | Cons. | Equity to asset ratio (5-year summary) |
| Equity ratio | 59.7% | at 2023-09-30 | Cons. | Equity to asset ratio (5-year summary) |
Periods use the dates stated in the filing. d = earlier-year period dated by calendar; v = that date confirmed by the company's own earlier filing.
Segments · 37
| Segment | Item | Period | Value |
|---|---|---|---|
| Reconciling Itemsreconciling | revenue | 2024-04-01 → 2024-09-30 | −¥48m |
| Reconciling Itemsreconciling | revenue intersegment | 2024-04-01 → 2024-09-30 | −¥48m |
| Reconciling Itemsreconciling | segment profit | 2024-04-01 → 2024-09-30 | −¥977m |
| jpcrp040300-q2r_E05236-000Global Businessreportable segment | revenue | 2024-04-01 → 2024-09-30 | ¥1.3bn |
| jpcrp040300-q2r_E05236-000Global Businessreportable segment | revenue external | 2024-04-01 → 2024-09-30 | ¥1.3bn |
| jpcrp040300-q2r_E05236-000Global Businessreportable segment | revenue intersegment | 2024-04-01 → 2024-09-30 | ¥24m |
| jpcrp040300-q2r_E05236-000Global Businessreportable segment | segment profit | 2024-04-01 → 2024-09-30 | −¥51m |
| jpcrp040300-q2r_E05236-000Medical Big Data Businessreportable segment | revenue | 2024-04-01 → 2024-09-30 | ¥1.1bn |
| jpcrp040300-q2r_E05236-000Medical Big Data Businessreportable segment | revenue external | 2024-04-01 → 2024-09-30 | ¥1.1bn |
| jpcrp040300-q2r_E05236-000Medical Big Data Businessreportable segment | revenue intersegment | 2024-04-01 → 2024-09-30 | ¥104,000 |
| jpcrp040300-q2r_E05236-000Medical Big Data Businessreportable segment | segment profit | 2024-04-01 → 2024-09-30 | ¥77m |
| jpcrp040300-q2r_E05236-000Package Businessreportable segment | revenue | 2024-04-01 → 2024-09-30 | ¥2.6bn |
| jpcrp040300-q2r_E05236-000Package Businessreportable segment | revenue external | 2024-04-01 → 2024-09-30 | ¥2.6bn |
| jpcrp040300-q2r_E05236-000Package Businessreportable segment | revenue intersegment | 2024-04-01 → 2024-09-30 | ¥1m |
| jpcrp040300-q2r_E05236-000Package Businessreportable segment | segment profit | 2024-04-01 → 2024-09-30 | ¥641m |
| Total Of Reportable Segments And Otherssegment total | revenue | 2024-04-01 → 2024-09-30 | ¥13.3bn |
| Total Of Reportable Segments And Otherssegment total | revenue external | 2024-04-01 → 2024-09-30 | ¥13.3bn |
| Total Of Reportable Segments And Otherssegment total | revenue intersegment | 2024-04-01 → 2024-09-30 | ¥48m |
| Total Of Reportable Segments And Otherssegment total | segment profit | 2024-04-01 → 2024-09-30 | ¥2.0bn |
| Reconciling Itemsreconciling | revenue | 2023-04-01 → 2023-09-30 | −¥89m |
| Reconciling Itemsreconciling | revenue intersegment | 2023-04-01 → 2023-09-30 | −¥89m |
| Reconciling Itemsreconciling | segment profit | 2023-04-01 → 2023-09-30 | −¥1.1bn |
| jpcrp040300-q2r_E05236-000Global Businessreportable segment | revenue | 2023-04-01 → 2023-09-30 | ¥1.7bn |
| jpcrp040300-q2r_E05236-000Global Businessreportable segment | revenue external | 2023-04-01 → 2023-09-30 | ¥1.7bn |
| jpcrp040300-q2r_E05236-000Global Businessreportable segment | revenue intersegment | 2023-04-01 → 2023-09-30 | ¥34m |
| jpcrp040300-q2r_E05236-000Global Businessreportable segment | segment profit | 2023-04-01 → 2023-09-30 | ¥204m |
| jpcrp040300-q2r_E05236-000Medical Big Data Businessreportable segment | revenue | 2023-04-01 → 2023-09-30 | ¥917m |
| jpcrp040300-q2r_E05236-000Medical Big Data Businessreportable segment | revenue external | 2023-04-01 → 2023-09-30 | ¥917m |
| jpcrp040300-q2r_E05236-000Medical Big Data Businessreportable segment | segment profit | 2023-04-01 → 2023-09-30 | ¥104m |
| jpcrp040300-q2r_E05236-000Package Businessreportable segment | revenue | 2023-04-01 → 2023-09-30 | ¥2.3bn |
| jpcrp040300-q2r_E05236-000Package Businessreportable segment | revenue external | 2023-04-01 → 2023-09-30 | ¥2.3bn |
| jpcrp040300-q2r_E05236-000Package Businessreportable segment | revenue intersegment | 2023-04-01 → 2023-09-30 | ¥407,000 |
| jpcrp040300-q2r_E05236-000Package Businessreportable segment | segment profit | 2023-04-01 → 2023-09-30 | ¥601m |
| Total Of Reportable Segments And Otherssegment total | revenue | 2023-04-01 → 2023-09-30 | ¥12.2bn |
| Total Of Reportable Segments And Otherssegment total | revenue external | 2023-04-01 → 2023-09-30 | ¥12.1bn |
| Total Of Reportable Segments And Otherssegment total | revenue intersegment | 2023-04-01 → 2023-09-30 | ¥89m |
| Total Of Reportable Segments And Otherssegment total | segment profit | 2023-04-01 → 2023-09-30 | ¥2.1bn |
Segment names come from EDINET member IDs; not yet mapped to a common taxonomy.
All source rows · 541
| Item | Context | Value | Unit |
|---|---|---|---|
| Revenues from external customers | CurrentYTDDuration_jpcrp040300-q2r_E05236-000MedicalBigDataBusinessReportableSegmentMember | 1132858000 | JPY |
| Revenues from external customers | CurrentYTDDuration_jpcrp040300-q2r_E05236-000GlobalBusinessReportableSegmentMember | 1321495000 | JPY |
| Revenues from external customers | CurrentYTDDuration_TotalOfReportableSegmentsAndOthersMember | 13260660000 | JPY |
| Revenues from external customers | CurrentYTDDuration_ReconcilingItemsMember | - | JPY |
| Revenues from external customers | CurrentYTDDuration | 13260660000 | JPY |
| Transactions with other segments | CurrentYTDDuration_jpcrp040300-q2r_E05236-000DXAndSIBusinessMember | 22210000 | JPY |
| Transactions with other segments | CurrentYTDDuration_jpcrp040300-q2r_E05236-000PackageBusinessReportableSegmentMember | 1361000 | JPY |
| Transactions with other segments | CurrentYTDDuration_jpcrp040300-q2r_E05236-000MedicalBigDataBusinessReportableSegmentMember | 104000 | JPY |
| Transactions with other segments | CurrentYTDDuration_jpcrp040300-q2r_E05236-000GlobalBusinessReportableSegmentMember | 23941000 | JPY |
| Transactions with other segments | CurrentYTDDuration_TotalOfReportableSegmentsAndOthersMember | 47616000 | JPY |
| Transactions with other segments | CurrentYTDDuration_ReconcilingItemsMember | -47616000 | JPY |
| Transactions with other segments | CurrentYTDDuration | - | JPY |
| Net sales | CurrentYTDDuration_jpcrp040300-q2r_E05236-000DXAndSIBusinessMember | 8261318000 | JPY |
| Net sales | CurrentYTDDuration_jpcrp040300-q2r_E05236-000PackageBusinessReportableSegmentMember | 2568559000 | JPY |
| Net sales | CurrentYTDDuration_jpcrp040300-q2r_E05236-000MedicalBigDataBusinessReportableSegmentMember | 1132962000 | JPY |
| Net sales | CurrentYTDDuration_jpcrp040300-q2r_E05236-000GlobalBusinessReportableSegmentMember | 1345436000 | JPY |
| Net sales | CurrentYTDDuration_TotalOfReportableSegmentsAndOthersMember | 13308276000 | JPY |
| Net sales | CurrentYTDDuration_ReconcilingItemsMember | -47616000 | JPY |
| Net sales | CurrentYTDDuration | 13260660000 | JPY |
| Operating income | CurrentYTDDuration_jpcrp040300-q2r_E05236-000DXAndSIBusinessMember | 1355416000 | JPY |
| Operating income | CurrentYTDDuration_jpcrp040300-q2r_E05236-000PackageBusinessReportableSegmentMember | 641194000 | JPY |
| Operating income | CurrentYTDDuration_jpcrp040300-q2r_E05236-000MedicalBigDataBusinessReportableSegmentMember | 77417000 | JPY |
| Operating income | CurrentYTDDuration_jpcrp040300-q2r_E05236-000GlobalBusinessReportableSegmentMember | -51423000 | JPY |
| Operating income | CurrentYTDDuration_TotalOfReportableSegmentsAndOthersMember | 2022604000 | JPY |
| Operating income | CurrentYTDDuration_ReconcilingItemsMember | -976926000 | JPY |
| Operating income | CurrentYTDDuration | 1045678000 | JPY |
| Document title cover page | FilingDateInstant | Original text (Japanese)半期報告書 | |
| Clause of stipulation cover page | FilingDateInstant | Original text (Japanese)金融商品取引法第24条の5第1項の表の第1号 | |
| Place of filing cover page | FilingDateInstant | Original text (Japanese)近畿財務局長 | |
| Filing date cover page | FilingDateInstant | 2024-11-12 | |
| Quarterly accounting period cover page | FilingDateInstant | Original text (Japanese)第53期中(自 2024年4月1日 至 2024年9月30日) | |
| Company name cover page | FilingDateInstant | Original text (Japanese)日本システム技術株式会社 | |
| Company name in english cover page | FilingDateInstant | Japan System Techniques Co., Ltd. | |
| Title and name of representative cover page | FilingDateInstant | Original text (Japanese)代表取締役社長 平林 武昭 | |
| Address of registered headquarter cover page | FilingDateInstant | Original text (Japanese)大阪市北区中之島二丁目3番18号 | |
| Telephone number address of registered headquarter cover page | FilingDateInstant | Original text (Japanese)06(4560)1000(代) | |
| Name of contact person address of registered headquarter cover page | FilingDateInstant | Original text (Japanese)取締役上席執行役員 平林 卓 | |
| Nearest place of contact cover page | FilingDateInstant | Original text (Japanese)大阪市北区中之島二丁目3番18号 | |
| Telephone number nearest place of contact cover page | FilingDateInstant | Original text (Japanese)06(4560)1000(代) | |
| Name of contact person nearest place of contact cover page | FilingDateInstant | Original text (Japanese)取締役上席執行役員 平林 卓 | |
| Place for public inspection cover page (text) | FilingDateInstant | Text · Plus | |
| Edinet code | FilingDateInstant | E05236 | |
| Fund code | FilingDateInstant | - | |
| Security code | FilingDateInstant | 43230 | |
| Filer name in japanese | FilingDateInstant | Original text (Japanese)日本システム技術株式会社 | |
| Filer name in english | FilingDateInstant | Japan System Techniques Co., Ltd. | |
| Fund name in japanese | FilingDateInstant | - | |
| Fund name in english | FilingDateInstant | - | |
| Cabinet office ordinance | FilingDateInstant | Original text (Japanese)企業内容等の開示に関する内閣府令 | |
| Document type | FilingDateInstant | Original text (Japanese)第四号の三様式 |
Every row of the EDINET CSV. Item names are the XBRL element names; filed text is kept in its original Japanese. Filed text is available on Plus and Pro.
Data checks · 14 of 14 passed
| balance sheet identity | pass rounding |
| balance sheet identity | pass |
| dei present | pass |
| period resolution | pass |
| statement vs summary · net assets | pass |
| statement vs summary · net assets | pass |
| statement vs summary · net income attributable to parent | pass |
| statement vs summary · net income attributable to parent | pass |
| statement vs summary · operating cash flow | pass |
| statement vs summary · operating cash flow | pass |
| statement vs summary · revenue | pass |
| statement vs summary · revenue | pass |
| statement vs summary · total assets | pass |
| statement vs summary · total assets | pass |